The expression of STAT3 target genes, Survivin, Bcl-2 and Bcl-xl, were decreased in SSMC 7721, Huh7, HEPG2 and Hep3B liver cancer cells after treatment with LY5 as examined by Western Blot (Figure 2A–2D). This evidence concerns the gene BIRC5 and liver cancer.